NFKB1 and Hyperglycemia: Another plausible mechanism is that hyperglycemia affects NF-κB, a key mediator that regulates multiple proinflammatory and proatherosclerotic target genes in endothelial cells, vascular smooth muscle cells, and macrophages [15, 16].